Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Abstract BACKGROUND New treatments are needed to reduce the risk of progression of coronavirus disease 2019 (Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is active agai…
